Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement/Warfarin Interactions Reviewed In AJHP Article

This article was originally published in The Tan Sheet

Executive Summary

Numerous dietary supplements, including coenzyme Q10 and dong quai, may cause adverse events due to possible interactions with the Rx anticoagulant warfarin, an article in the July 1 American Journal of Health-System Pharmacy notes.

You may also be interested in...



St. John's Wort, Rx Drug Use Warning Adopted By CHPA

Consumer Healthcare Products Association member companies soon will be incorporating a prescription drug use warning on their St. John's wort supplements.

Ephedra Alkaloid Content Markedly Different From Label Claims - Study

Controlled, human trials are needed to determine the safety and efficacy of ephedra supplements containing stimulant ingredients, University of Arkansas for Medical Sciences College of Pharmacy researchers say in a study slated to appear in the May 15 issue of the American Journal of Health-System Pharmacy.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS091419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel